Intrinsic Value of S&P & Nasdaq Contact Us

Arcturus Therapeutics Holdings Inc. ARCT NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$22.50
+159.2%

Stock Statistics — ARCT

Arcturus Therapeutics Holdings Inc. (ARCT) has a market capitalization of $246.71M and trades at $8.68. The 52-week range is 5.85-24.17.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.6, Earnings Per Share (EPS) of $-2.40, annual revenue of $67.22M.

The stock has a beta of 2.44, operates in the Healthcare sector.

Trading Data
Current Price$8.68
52-Week Range5.85-24.17
Volume332.2K
Avg Volume (30D)529.47K
Market Cap$246.71M
Beta (1Y)2.44
Company
IPO Date2013-05-22
Employees174
CEOJoseph E. Payne
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS03969T1097
CUSIP03969T109
Income (Latest Year)
Revenue$67.22M
Gross Profit$64.2M
EBITDA$-71.93M
Operating Income$-74.96M
Net Income$-65.78M
EPS$-2.40
EPS Diluted$-2.40
Shares Outstanding$27.39M
Balance Sheet (Latest Year)
Total Assets$271.15M
Current Assets$241.45M
Cash & ST Investments$230.91M
Total Liabilities$57.16M
Total Debt$25M
Net Debt$-205.91M
Total Equity$213.99M
Debt / Equity0.12
Valuation Ratios
P/E Ratio-3.6
P/S Ratio3.67
P/B Ratio1.15
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message